/R E P E A T -- Magnet-Like Nanoparticle Vaccine Achieves 100% Protection Against H5N1 in Preclinical Trials/

/R E P E A T -- Magnet-Like Nanoparticle Vaccine Achieves 100% Protection Against H5N1 in Preclinical Trials/

BUFFALO-NIAGARA, N.Y., April 17, 2025 /PRNewswire/ - As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off POP Biotechnologies has demonstrated complete protection in preclinical trials. This advancement arrives…

May 8 webinar to focus on vaccine for Avian Influenza in dairy cattle

ORANGE CITY, Iowa — The I-29 Moo University Dairy Webinar series continues from noon to 1 p.m. May 8, focusing on an avian influenza vaccine development with Dr. Alan Young. Young founded VST/Medgene Labs to assist in the translation of early stage technologies to the marketplace and to develop new vaccine and diagnostic tools for human and veterinary medicine. He will discuss how Medgene’s platform is being applied toward a vaccine for Avian In…

New bird flu vaccine works really well in mice

A new vaccine under development offers complete protection in mice against a deadly variant of the virus that causes bird flu. The work, detailed in a study in the journal Cell Biomaterials, focuses on the H5N1 variant known as 2.3.4.4b, which has caused widespread outbreaks in wild birds and poultry, in addition to infecting dairy cattle, domesticated cats, sea lions, and other mammals. In the study, scientists describe a process they’ve develo…